# Minerva Neurosciences, Inc.: filings

NERV · Nasdaq · CIK 1598646 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nerv.md) · [Financials](/companies/nerv/financials.md) · [Filings](/companies/nerv/filings.md) · [Insiders](/companies/nerv/insiders.md)

## Reports and events: 216 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 225, 8-K 129, 10-Q 37, 3 29, SC 13G/A 24, CORRESP 14, 10-K 12, DEF 14A 12, DEFA14A 11, SC 13G 11, UPLOAD 10, S-8 9, SC 13D/A 9, EFFECT 8, 424B3 7, SCHEDULE 13G 7, 144 6, S-3 6, 10-K/A 5, 424B5 5, ARS 4, PRE 14A 4, S-1/A 4, SC 13D 4, SCHEDULE 13G/A 4, D 3, 3/A 2, 424B4 2, S-1 2, SC TO-I/A 2, 4/A 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, CT ORDER 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, POS AM 1, RW 1, SCHEDULE 13D/A 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 16:05 ET | [8-K](/filings/0001193125-26-346817.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-346817 |
| 2026-08-07 | 07:30 ET | [10-Q](/filings/0001193125-26-339171.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339171 |
| 2026-08-07 | 07:13 ET | [8-K](/filings/0001193125-26-339147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-339147 |
| 2026-06-04 | 16:05 ET | [8-K](/filings/0001193125-26-257379.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257379 |
| 2026-05-27 | 16:18 ET | [8-K](/filings/0001193125-26-241930.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-241930 |
| 2026-05-05 | 08:30 ET | [10-Q](/filings/0001193125-26-205182.md) | Quarterly report, period 2026-03-31 | 0001193125-26-205182 |
| 2026-05-05 | 08:09 ET | [8-K](/filings/0001193125-26-205129.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205129 |
| 2026-04-23 | 07:00 ET | [DEF 14A](/filings/0001193125-26-171799.md) | Proxy statement, period 2026-06-03 | 0001193125-26-171799 |
| 2026-04-06 | 17:07 ET | [8-K](/filings/0001193125-26-143986.md) | 8.01 Other events | 0001193125-26-143986 |
| 2026-04-02 | 16:15 ET | [8-K](/filings/0001193125-26-140148.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-140148 |
| 2026-03-11 | 08:00 ET | [10-K](/filings/0001193125-26-101117.md) | Annual report, period 2025-12-31 | 0001193125-26-101117 |
| 2026-03-11 | 07:07 ET | [8-K](/filings/0001193125-26-101074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-101074 |
| 2026-02-03 | 09:00 ET | [8-K](/filings/0001193125-26-034538.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-034538 |
| 2025-12-30 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001193125-25-337075.md) | Ownership report, active investor, amended | 0001193125-25-337075 |
| 2025-12-22 | 16:05 ET | [8-K](/filings/0001193125-25-328715.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-328715 |
| 2025-11-24 | 16:05 ET | [DEF 14A](/filings/0001193125-25-293674.md) | Proxy statement, period 2025-12-22 | 0001193125-25-293674 |
| 2025-11-19 | 08:40 ET | [8-K](/filings/0001193125-25-287048.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-287048 |
| 2025-11-05 | 07:00 ET | [10-Q](/filings/0001193125-25-265685.md) | Quarterly report, period 2025-09-30 | 0001193125-25-265685 |
| 2025-10-22 | 20:25 ET | [8-K](/filings/0001193125-25-245552.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-245552 |
| 2025-08-14 | 16:03 ET | [10-Q](/filings/0000950170-25-108840.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108840 |
| 2025-05-13 | 07:00 ET | [10-Q](/filings/0000950170-25-069780.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069780 |
| 2025-04-29 | 18:46 ET | [10-K/A](/filings/0001193125-25-100977.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-100977 |
| 2025-04-21 | 16:55 ET | [10-K/A](/filings/0001193125-25-087311.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-087311 |
| 2025-03-19 | 16:43 ET | [8-K](/filings/0001193125-25-057901.md) | 8.01 Other events | 0001193125-25-057901 |
| 2025-02-25 | 06:30 ET | [10-K](/filings/0000950170-25-026055.md) | Annual report, period 2024-12-31 | 0000950170-25-026055 |
| 2025-01-13 | 08:46 ET | [8-K](/filings/0001193125-25-005042.md) | 8.01 Other events | 0001193125-25-005042 |
| 2024-12-05 | 17:21 ET | [8-K](/filings/0001193125-24-271652.md) | 5.07 Shareholder vote results | 0001193125-24-271652 |
| 2024-11-05 | 07:00 ET | [10-Q](/filings/0000950170-24-121063.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121063 |
| 2024-10-22 | 07:06 ET | [DEF 14A](/filings/0001193125-24-240733.md) | Proxy statement, period 2024-12-05 | 0001193125-24-240733 |
| 2024-10-11 | 16:10 ET | [8-K](/filings/0001193125-24-236726.md) | 3.01 Delisting notice | 0001193125-24-236726 |
| 2024-09-16 | 16:05 ET | [8-K](/filings/0001193125-24-219590.md) | 8.01 Other events | 0001193125-24-219590 |
| 2024-08-06 | 07:01 ET | [10-Q](/filings/0000950170-24-091195.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091195 |
| 2024-05-30 | 16:25 ET | [8-K](/filings/0001193125-24-150357.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-150357 |
| 2024-05-01 | 07:00 ET | [10-Q](/filings/0000950170-24-050883.md) | Quarterly report, period 2024-03-31 | 0000950170-24-050883 |
| 2024-04-22 | 17:07 ET | [10-K/A](/filings/0001193125-24-105033.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-105033 |
| 2024-04-12 | 16:05 ET | [8-K](/filings/0001193125-24-094620.md) | 3.01 Delisting notice | 0001193125-24-094620 |
| 2024-02-27 | 08:04 ET | [8-K](/filings/0001193125-24-047110.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-047110 |
| 2024-02-26 | 17:32 ET | [10-K/A](/filings/0001193125-24-044724.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-044724 |
| 2024-02-22 | 06:30 ET | [10-K](/filings/0000950170-24-018392.md) | Annual report, period 2023-12-31 | 0000950170-24-018392 |
| 2023-11-07 | 07:00 ET | [10-Q](/filings/0000950170-23-059747.md) | Quarterly report, period 2023-09-30 | 0000950170-23-059747 |
| 2023-09-28 | 16:05 ET | [8-K](/filings/0001193125-23-245615.md) | 5.07 Shareholder vote results | 0001193125-23-245615 |
| 2023-08-15 | 09:25 ET | [DEF 14A](/filings/0001193125-23-213100.md) | Proxy statement, period 2023-09-27 | 0001193125-23-213100 |
| 2023-08-01 | 07:01 ET | [10-Q](/filings/0000950170-23-036159.md) | Quarterly report, period 2023-06-30 | 0000950170-23-036159 |
| 2023-07-07 | 16:18 ET | [SC 13D](/filings/0001193125-23-183809.md) | Ownership report, active investor | 0001193125-23-183809 |
| 2023-06-28 | 08:37 ET | [8-K](/filings/0001193125-23-176877.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-176877 |
| 2023-06-20 | 08:41 ET | [8-K](/filings/0001193125-23-169682.md) | 8.01 Other events | 0001193125-23-169682 |
| 2023-06-02 | 16:05 ET | [8-K](/filings/0001193125-23-159827.md) | 3.01 Delisting notice | 0001193125-23-159827 |
| 2023-05-15 | 07:01 ET | [10-Q](/filings/0000950170-23-021947.md) | Quarterly report, period 2023-03-31 | 0000950170-23-021947 |
| 2023-05-05 | 16:18 ET | [8-K](/filings/0001193125-23-137134.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-137134 |
| 2023-05-01 | 07:18 ET | [8-K](/filings/0001193125-23-128726.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-128726 |

Page 1 of 5. [Older](/companies/nerv/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:30 ET. No prices; not investment advice.